We are experiencing some temporary issues. The market data on this page are currently delayed. Please bear with us as we address this and restore your personalized lists.

U.S. markets close in 2 hours 58 minutes

Victory Square Technologies Inc. (VSQTF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.4549+0.0174 (+3.98%)
As of 11:43AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.4375
Open0.4290
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.4290 - 0.4699
52 Week Range0.0260 - 0.8366
Volume36,116
Avg. Volume449,571
Market Cap34.224M
Beta (5Y Monthly)2.16
PE Ratio (TTM)64.99
EPS (TTM)0.0070
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Victory Square Technologies Portfolio Company enters into Sales & Distribution agreement with the Canadian Gaming Association
    GlobeNewswire

    Victory Square Technologies Portfolio Company enters into Sales & Distribution agreement with the Canadian Gaming Association

    CGA members will be able to access on-site rapid testing for Covid-19 subject to Health Canada approvals * Gaming in Canada supports over 180,000 jobs* * Annually, pre-Covid-19 saw over 50,000,000 visits to gaming properties across Canada* * Pre-Covid-19, the industry purchased over $14.6 billion in goods and services annually, generating $18.9 billion of value-added GDP to the Canadian economy* * Providing access to rapid testing is an important tool to help reopen the economy and assist the hospitality industryVANCOUVER, British Columbia, Oct. 22, 2020 (GLOBE NEWSWIRE) -- Victory Square Health Inc. (“VS Health” or the "Company") – a portfolio company of Victory Square Technologies Inc. ("Victory Square'') (CSE:VST) (OTC:VSQTF) (FWB:6F6) has entered into an agreement with the Canadian Gaming Association (CGA), a national trade association representing the leading operators and suppliers in Canada’s casino gaming and lottery industry subject to Health Canada approval.The Company announced on October 6, 2020 that it had submitted all formal documents and research for Health Canada approval of its proprietary Safetest Covid-19 Rapid test. This sales, distribution and testing agreement will enable VS Health to assist the members of one of Canada’s largest hospitality industry associations ensuring the health and safety of the 180,000 employees that make up the gaming industry in Canada. Before the industry shut down in March, Canadian casino and bingo operators had over 50 million unique visits annually to their properties.This Safetest Covid-19 Rapid Test complement will allow each participating property to access rapid, easy, efficient and cost-effective daily Covid-19 Rapid tests to ensure employees are not infected with the Covid-19 virus, which will in turn keep workplaces safe. The test may also be administered to customers, subject to Health Canada approvals.“We are very pleased to engage with Victory Square Health,” said Paul Burns, President and CEO of the Canadian Gaming Association. “We believe that providing access to rapid testing, like the Safetest Rapid Test product, is one of the most important tools to help reopen our economy and to allow for greater confidence in increasing capacities in venues across the hospitality industry.”“I am delighted with this important agreement with the CGA so that Victory Square Health may realize its goal of commencing distribution of its exclusive Rapid Test kits on a national scale,” said Victory Square CEO Shafin D. Tejani. “The gaming and entertainment industries have been adversely affected by this pandemic and we are confident that our products and testing services will enable these properties to reopen and increase capacity through our Covid-19 tests. We look forward to providing our Safetest Rapid Test kits and testing services to all companies affected by Covid-19 following Health Canada approvals so that they can get their teams back to work and help grow our economy.”Victory Square Health is committed to assisting Canadians and Canadian organizations. The company recently announced a strategic partnership with the Canadian Police Association and its members across Canada.VS Health was founded in 2016 to accelerate the development of personalized medicine and technology solutions including diagnostic tests to support patient care and improve health outcomes. Its first product, the Leishmaniasis Rapid Test, was developed in partnership with the UFMG, Federal University of Minas Gerais. Safetest took advantage of its expertise in the subject to develop other antibody-based tests and a robust R&D pipelines of diagnostic kits for Hansen’s Disease, Brucellosis, HTLV and blood sample screening tests.Disclaimer:The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the Covid-19 (or SARS-2 Coronavirus) at this time.*These figures have been vetted by the Canadian Gaming AssociationGo to: VictorySquare.com and sign up for VST’s official newsletter at www.VictorySquare.com/newsletterOn behalf of the board,Shafin Diamond Tejani Chief Executive Officer Victory Square TechnologiesFor further information about the Company, please contact:Investor Relations Contact – Alex Tzilios Email: alexandros@victorysquare.com Telephone: 778-867-0482Media Relations Contact – Howard Blank, Director Email: howard@victorysquare.com Telephone: 604-928-6066ABOUT VICTORY SQUARE TECHNOLOGIES INC.Victory Square (VST) builds, acquires and invests in promising startups, then provides the senior leadership and resources needed to fast-track growth.VST's sweet spot is the cutting-edge tech that's shaping the 4th Industrial Revolution. Our portfolio consists of 23 global companies using AI, VR/AR and blockchain to disrupt sectors as diverse as fintech, insurance, health and gaming.What we do differently for startupsVST isn't just another investor. With real skin in the game, we're committed to ensuring each company in our portfolio succeeds. Our secret sauce starts with selecting startups that have real solutions, not just ideas. We pair you with senior talent in product, engineering, customer acquisition and more. Then we let you do what you do best — build, innovate and disrupt. In 24-36 months, you'll scale and be ready to monetize.What we do differently for investorsVST is a publicly traded company headquartered in Vancouver, Canada, and listed on the Canadian Securities Exchange (VST), Frankfurt Exchange (6F6) and the OTCQX (VSQTF).For investors, we offer early-stage access to the next unicorns before they're unicorns.Our portfolio represents a uniquely liquid and secure way for investors to get access to the latest cutting-edge technologies while also tapping into emerging global trends with big upsides. For more information, please visit www.victorysquare.com.ABOUT CGA:The Canadian Gaming Association (CGA) is a national trade association that works to advance the evolution of Canada’s gaming industry. The association’s mandate is to promote the economic value of gaming in Canada; use research, innovation, and best practices to help the industry advance; and create productive dialogue among stakeholders.Forward Looking StatementThis news release contains “forward-looking information” within the meaning of applicable securities laws relating to the outlook of the business of Victory Square, including, without limitation, statements relating to future performance, execution of business strategy, future growth, business prospects and opportunities of Victory Square and its related subsidiaries, including Victory Square Health Inc., and other factors beyond our control. Such forward-looking statements may, without limitation, be preceded by, followed by, or include words such as “believes”, “expects”, “anticipates”, “estimates”, “intends”, “plans”, “continues”, “project”, “potential”, “possible”, “contemplate”, “seek”, “goal”, or similar expressions, or may employ such future or conditional verbs as “may”, “might”, “will”, “could”, “should” or “would”, or may otherwise be indicated as forward-looking statements by grammatical construction, phrasing or context. All statements other than statements of historical facts contained in this news release are forward-looking statements. Forward-looking information is based on certain key expectations and assumptions made by the management of Victory Square. Although Victory Square believes that the expectations and assumptions on which such forward looking information is based are reasonable, undue reliance should not be placed on them because Victory Square can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements contained in this news release are made as of the date of this news release. Victory Square disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.

  • CNW Group

    IIROC Trade Resumption - VST

    VANCOUVER, BC, Oct. 21, 2020 /CNW/ - Trading resumes in:Company: Victory Square Technologies Inc.

  • Victory Square Technologies Announces $4 Million Private Placement of Special Warrants Led by Gravitas Securities
    GlobeNewswire

    Victory Square Technologies Announces $4 Million Private Placement of Special Warrants Led by Gravitas Securities

    THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. VANCOUVER, British Columbia, Oct. 20, 2020 (GLOBE NEWSWIRE) -- Victory Square Technologies Inc. ("Victory Square" or the "Company") (CSE: VST) (OTC: VSQTF) (FWB: 6F6) announces that it has entered into an agreement with Gravitas Securities Inc. (the "Lead Agent"), on its own behalf and on behalf of a syndicate of agents (collectively, the "Agents"), for an offering on commercially reasonable best efforts basis of 7,692,308 non-transferable special warrants of the Company (the "Special Warrants") at a price of $0.52 per Special Warrant, for aggregate gross proceeds of approximately $4 million (the "Private Placement Offering"). The Company has also granted the Agents an option to purchase up to an additional 15% of the base offering of Special Warrants (the "Over-Allotment Option"), which option is exercisable by the Agents, in whole or in part, at any time up to 30 days following the closing of the Private Placement Offering. Closing of the Private Placement Offering is expected to occur on or around November 17, 2020, or such other date as the Lead Agent and the Company may agree (the "Initial Closing Date").Each Special Warrant will entitle the holder thereof to receive one unit of Victory Square (a "Unit"), without payment of additional consideration, with each Unit being comprised of one common share of the Company (a "Share") and one-half of one non-transferable common share purchase warrant of the Company (each whole such warrant, a "Warrant"). Each Warrant will entitle the holder thereof to purchase an additional common share of the Company (a "Warrant Share") at a price of $0.78 per share for a period of 36 months from the Initial Closing Date.The Company has agreed to prepare and file a short form prospectus (the "Prospectus") qualifying the distribution of the Shares and the Warrants in British Columbia, Alberta, Manitoba and Ontario. In the event a receipt for the preliminary Prospectus has not been issued within 60 days of the Initial Closing Date, each Special Warrant will, upon the earlier of (i) four months and one day following the Initial Closing Date (or such subsequent closing date as may be applicable) and (ii) the date of the issuance of the receipt for the final Prospectus, entitle the holder of the Special Warrant to receive, at no additional cost, 1.10 Units, provided that the Company shall not be required to issue fractional Units, Shares or Warrants and any fractions shall be rounded down to the nearest whole number.Until a receipt is issued for the final Prospectus, securities issued in connection with the Private Placement Offering will be subject to a 4-month hold period from the date of issue.The net proceeds of the Offering are expected to be used for future acquisitions, organic growth investments, working capital and general corporate purposes.The closing of the Private Placement Offering is subject to the completion of formal documentation, including but not limited to, the execution of an agency agreement with the Agents in connection with the Offering and receipt of regulatory approvals, including approval of the Canadian Securities Exchange.In connection with the Private Placement Offering, the Company has agreed to pay the Agents a cash commission equal to 8% of the aggregate gross proceeds received by the Company from the sale of the Special Warrants (including pursuant to the Over-Allotment Option), which will be reduced to 6% for purchasers included on a president's list provided to the Agents by the Company (the "President's List"). The Company has also agreed to issue to the Agents such number of non-transferable common share purchase warrants (the "Agents' Warrants") as is equal to 8% of the aggregate number of Special Warrants issued under the Private Placement Offering (including pursuant to the Over-Allotment Option), which will be reduced to 6% for purchasers included on the President's List.For further information about the Company, please contact:Investor Relations Contact – Alex TziliosEmail: alexandros@victorysquare.comTelephone: 778-867-0482Media Relations Contact – Howard Blank, DirectorEmail: howard@victorysquare.comTelephone: 604-928-6066ABOUT VICTORY SQUARE TECHNOLOGIES INC.Victory Square (VST) builds, acquires and invests in promising startups, then provides the senior leadership and resources needed to fast-track growth.VST's sweet spot is the cutting-edge tech that's shaping the 4th Industrial Revolution. Our portfolio consists of 20 global companies using AI, VR/AR and blockchain to disrupt sectors as diverse as fintech, insurance, health and gaming.What we do differently for startups VST isn't just another investor. With real skin in the game, we're committed to ensuring each company in our portfolio succeeds. Our secret sauce starts with selecting startups that have real solutions, not just ideas. We pair you with senior talent in product, engineering, customer acquisition and more. Then we let you do what you do best — build, innovate and disrupt. In 24- 36 months, you'll scale and be ready to monetize.What we do differently for investorsVST is a publicly traded company headquartered in Vancouver, Canada, and listed on the Canadian Securities Exchange (VST), Frankfurt Exchange (6F6) and the OTCQX (VSQTF).For investors, we offer early-stage access to the next unicorns before they're unicorns.Forward Looking StatementCertain statements in this news release related to the Company are forward-looking statements and are prospective in nature. Forward-looking statements are not based on historical facts, but rather on current expectations and projections about future events, and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements. These statements generally can be identified by the use of forward-looking words such as "may", "should", "could", "intend", "estimate", "plan", "anticipate", "expect", "believe" or "continue", or the negative thereof or similar variations. Forward-looking statements in this news release include statements regarding the closing of the Private Placement Offering, the intended use of proceeds of the Offering, the filing of the Prospectus and the obtaining of receipts for the Prospectus. There are numerous risks and uncertainties that could cause actual results and the Company's plans and objectives to differ materially from those expressed in the forward-looking information, including: (i) adverse market conditions; (ii) risks inherent in the Company's business in general; (iii) that the proceeds of the Offering may need to be used for purposes other than as set out in this news release and other factors beyond the control of the Company. Actual results and future events could differ materially from those anticipated in such information. These and all subsequent written and oral forward- looking information are based on estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. Except as required by applicable law, the Company does not intend to update these forward-looking statements.The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.Our portfolio represents a uniquely liquid and secure way for investors to get access to the latest cutting-edge technologies while also tapping into emerging global trends with big upsides. For more information, please visit www.victorysquare.com.

  • CNW Group

    IIROC Trading Halt - VST

    VANCOUVER, BC, Oct. 20, 2020 /CNW/ - The following issues have been halted by IIROC:Company: Victory Square Technologies Inc.

  • GlobeNewswire

    Victory Square Technologies Portfolio Company Receives Approval for Sale & Distribution of 15 Minute 96.6% Sensitivity Safetest Covid-19 Rapid Test for the European Union

    * Victory Square Health received CE from EU competent authority of Belgium for Safetest 15 Minute Rapid Test antibody test for distribution, sale, and usage throughout the European Union on October 16, 2020 * The Safetest 15 Minute Covid-19 Rapid Test has a 96.6% Sensitivity, and can confirm whether one is currently infected with the virus causing Covid-19 or whether one was infected before and was unaware of the infection * Over 4.5 million Covid-19 cases and 198,886 deaths reported in the EU / EEA as of October 17, 2020 * This Safetest Covid-19 Rapid Test approval now enables Victory Square Health to distribute throughout the 27 countries and 446M inhabitants, which make up the European Union * This EU approval for the Safetest 15 Minute Rapid Test is in addition to the Company’s proprietary Elisa test approval issued by the EU / EEA on September 14, 2020 VANCOUVER, British Columbia, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Victory Square Health Inc. (“VS Health” or the “Company“) – a portfolio company of Victory Square Technologies Inc. (“Victory Square“) (CSE:VST) (OTC:VSQTF) (FWB:6F6) announced today that it was granted EU declaration of conformity which indicates that a product complies with all the requirements of European IVDD (in-vitro diagnostic device) legislation. The CE designation allows the company to commence marketing, sales and distribution of its Safetest 15 Minute Rapid Test Covid-19 assay for detecting the antibodies IgG and IgM against SARS-CoV-2, for the European Union through May 2022.   The Safetest 15 Minute Covid-19 Rapid Test enables the user / administrator to receive test results with a 96.6% accuracy in 15 minutes by a simple blood sample similar to that of a hand held pregnancy stick / diabetes reader. This highly accurate test enables the participant / administrator to quickly detect if they have Covid-19 antibodies, and thus show infection in less than 15 minutes.The European Union has seen 4.5 million Covid-19 cases as of October 16, 2020. On October 16, 2020 Europe set a record of Coronavirus cases overtaking the United States in cases per capita. The Safetest 15 minute Covid-19 Rapid Test is designed to provide accurate data to persons to help prevent the spread of this virus. This approval for the Safetest Covid-19 15 minute Rapid Test is in addition to the Elisa Test approval given to the Company by the EU / EEA on September 14, 2020.VS Health was founded in 2016 to accelerate the development of personalized medicine and technology solutions including diagnostic tests to support patient’s care and improve health outcomes. Its first product, the Leishmaniasis Rapid Test, was developed in partnership with the UFMG, Federal University of Minas Gerais. Safetest took advantage of its expertise in the subject to develop other antibody-based tests and a robust R&D pipelines of diagnostic kits for Hansen’s Disease, Brucellosis, HTLV and Blood samples screening tests.This Safetest Covid-19 Rapid Test approval allows Victory Square Health to distribute throughout the following 27 EU & EEA countries with a combined population of 446,824,564: * Austria, Belgium, Bulgaria, Croatia, Republic of Cyprus, Czech, Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden Disclaimer:The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the Covid-19 (or SARS-2 Coronavirus) at this timeCheck out VictorySquare.com and sign up to VST’s official newsletter at www.VictorySquare.com/newsletterOn behalf of the board,Shafin Diamond Tejani Chief Executive Officer Victory Square TechnologiesFor further information about the Company, please contact:Investor Relations Contact – Alex TziliosEmail: alexandros@victorysquare.comTelephone: 778-867-0482Media Relations Contact – Howard Blank, DirectorEmail: howard@victorysquare.comTelephone: 604-928-6066ABOUT VICTORY SQUARE TECHNOLOGIES INC.Victory Square (VST) builds, acquires and invests in promising startups, then provides the senior leadership and resources needed to fast-track growth.VST's sweet spot is the cutting-edge tech that's shaping the 4th Industrial Revolution. Our portfolio consists of 20 global companies using AI, VR/AR and blockchain to disrupt sectors as diverse as fintech, insurance, health and gaming.What we do differently for startupsVST isn't just another investor. With real skin in the game, we're committed to ensuring each company in our portfolio succeeds. Our secret sauce starts with selecting startups that have real solutions, not just ideas. We pair you with senior talent in product, engineering, customer acquisition and more. Then we let you do what you do best — build, innovate and disrupt. In 24-36 months, you'll scale and be ready to monetize.What we do differently for investorsVST is a publicly traded company headquartered in Vancouver, Canada, and listed on the Canadian Securities Exchange (VST), Frankfurt Exchange (6F6) and the OTCQX (VSQTF).For investors, we offer early-stage access to the next unicorns before they're unicorns.Our portfolio represents a uniquely liquid and secure way for investors to get access to the latest cutting-edge technologies while also tapping into emerging global trends with big upsides. For more information, please visit www.victorysquare.com.Forward Looking StatementThis news release contains “forward-looking information” within the meaning of applicable securities laws relating to the outlook of the business of Victory Square, including, without limitation, statements relating to future performance, execution of business strategy, future growth, business prospects and opportunities of Victory Square and its related subsidiaries, including Victory Square Health Inc., and other factors beyond our control. Such forward-looking statements may, without limitation, be preceded by, followed by, or include words such as “believes”, “expects”, “anticipates”, “estimates”, “intends”, “plans”, “continues”, “project”, “potential”, “possible”, “contemplate”, “seek”, “goal”, or similar expressions, or may employ such future or conditional verbs as “may”, “might”, “will”, “could”, “should” or “would”, or may otherwise be indicated as forward-looking statements by grammatical construction, phrasing or context. All statements other than statements of historical facts contained in this news release are forward-looking statements. Forward-looking information is based on certain key expectations and assumptions made by the management of Victory Square. Although Victory Square believes that the expectations and assumptions on which such forward looking information is based are reasonable, undue reliance should not be placed on them because Victory Square can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements contained in this news release are made as of the date of this news release. Victory Square disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.

  • GlobeNewswire

    Victory Square Technologies Portfolio Company Establishes Distribution Network in Hong Kong, Philippines, Malaysia, Thailand, & Singapore for Safetest Covid-19 Testing Kits

    * Victory Square Health’s newly announced distribution network will provide accurate and affordable Safetest Covid-19 testing kits in Hong Kong, Philippines, Malaysia, Thailand, & Singapore * Sales and distribution of VS Health products subject to Government/Health approvals. * Safetest Covid-19 Testing kits can confirm whether one is currently infected with the virus causing Covid-19 or whether one was infected before and was unaware of the infection VANCOUVER, British Columbia, Oct. 15, 2020 (GLOBE NEWSWIRE) -- Victory Square Health Inc. (“VS Health” or the "Company") – a portfolio company of Victory Square Technologies Inc. ("Victory Square'') (CSE:VST) (OTC:VSQTF) (FWB:6F6) -- is pleased to announce that it has established a distribution network in Hong Kong, Philippines, Malaysia, Thailand and Singapore to make available its Safetest Covid-19 Testing Kits across the region.The new partnerships with Hong Kong-based Nupaf Ltd., Jaya Unggul Gemilang Sdn Bhd in Malaysia, an associate company of the Singapore-based Olim Het Pte. Ltd. and Added Value Business and Marketing Solutions Inc. based in the Philippines, will provide the region with access to VS Health’s ELISA and Safetest 15 Minute Rapid Covid-19 assay for detecting the antibodies IgG and IgM against SARS-CoV-2. This will commence immediately following regional approvals.Over the past decade, NUPAF’s diverse client base includes organizations such as the United Nations and NATO to hotel chains including Sheraton, Ritz Carlton and exclusive private clubs. “We are very pleased and proud to work with Victory Square,” said Francis Anthony of Jaya Unggul Gemilang Sdn Bhd in Malaysia, an associate company of the Singapore-based Olim Het Pte. Ltd., which specialises in the sourcing of medical products/supplies with clients in Singapore, Malaysia, Thailand and Australia.The Safetest 15 Minute Covid-19 Rapid Test enables the user to receive results with a 96.6% sensitivity in 15 minutes by a simple blood sample similar to that of a hand held diabetes reader that resembles a pregnancy test stick. This highly accurate test enables the participant to quickly detect if they have Covid-19 antibodies in 15 minutes.The Safetest 15 Minute Covid-19 Rapid Test has been granted permission by the Food & Drug Administration (FDA) in the United States to commence marketing, sales and distribution under the emergency use authorization (EUA). The Safetest 15 Minute Covid-19 Rapid Test has been submitted for review and approval in Canada and the European Union.The newly created VS Health network in South East Asia will also receive access to the company’s other antibody-based tests and its robust R&D pipeline of diagnostic kits for Hansen’s Disease, Brucellosis, HTLV and Blood samples screening tests.Many countries in South East Asia are in the grips of a second pandemic shutdown, and the deployment of rapid tests is seen as the best way to support sectors of the economy that have been crushed by public health measures meant to slow the spread of Covid-19.“Rapid tests to detect the presence of the virus, which are faster and cheaper, are a vital addition to the testing arsenal needed to contain and fight Covid-19 in the region,” said Victory Square CEO Shafin Diamond Tejani. “Our company is now collaborating with our distributors in Asia in submitting for health and government approvals,” he said.VS Health was founded in 2016 to accelerate the development of personalized medicine and technology solutions including diagnostic tests to support patient’s care and improve health outcomes. Its first product, the Leishmaniasis Rapid Test, was developed in partnership with the UFMG, Federal University of Minas Gerais. Safetest took advantage of its expertise in the subject to develop other antibody-based tests and a robust R&D pipelines of diagnostic kits for Hansen’s Disease, Brucellosis, HTLV and Blood samples screening tests.Disclaimer:The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the Covid-19 (or SARS-2 Coronavirus) at this timeGo to: VictorySquare.com and sign up for VST’s official newsletter at www.VictorySquare.com/newsletterOn behalf of the board,Shafin Diamond TejaniChief Executive OfficerVictory Square TechnologiesFor further information about the Company, please contact:Investor Relations Contact – Alex TziliosEmail: alexandros@victorysquare.comTelephone: 778-867-0482Media Relations Contact – Howard Blank, DirectorEmail: howard@victorysquare.comTelephone: 604-928-6066ABOUT VICTORY SQUARE TECHNOLOGIES INC.Victory Square (VST) builds, acquires and invests in promising startups, then provides the senior leadership and resources needed to fast-track growth.VST's sweet spot is the cutting-edge tech that's shaping the 4th Industrial Revolution. Our portfolio consists of 20 global companies using AI, VR/AR and blockchain to disrupt sectors as diverse as fintech, insurance, health and gaming.What we do differently for startupsVST isn't just another investor. With real skin in the game, we're committed to ensuring each company in our portfolio succeeds. Our secret sauce starts with selecting startups that have real solutions, not just ideas. We pair you with senior talent in product, engineering, customer acquisition and more. Then we let you do what you do best — build, innovate and disrupt. In 24-36 months, you'll scale and be ready to monetize.What we do differently for investorsVST is a publicly traded company headquartered in Vancouver, Canada, and listed on the Canadian Securities Exchange (VST), Frankfurt Exchange (6F6) and the OTCQX (VSQTF).For investors, we offer early-stage access to the next unicorns before they're unicorns.Our portfolio represents a uniquely liquid and secure way for investors to get access to the latest cutting-edge technologies while also tapping into emerging global trends with big upsides. For more information, please visit www.victorysquare.com.Forward Looking StatementThis news release contains “forward-looking information” within the meaning of applicable securities laws relating to the outlook of the business of Victory Square, including, without limitation, statements relating to future performance, execution of business strategy, future growth, business prospects and opportunities of Victory Square and its related subsidiaries, including Victory Square Health Inc., and other factors beyond our control. Such forward-looking statements may, without limitation, be preceded by, followed by, or include words such as “believes”, “expects”, “anticipates”, “estimates”, “intends”, “plans”, “continues”, “project”, “potential”, “possible”, “contemplate”, “seek”, “goal”, or similar expressions, or may employ such future or conditional verbs as “may”, “might”, “will”, “could”, “should” or “would”, or may otherwise be indicated as forward-looking statements by grammatical construction, phrasing or context. All statements other than statements of historical facts contained in this news release are forward-looking statements. Forward-looking information is based on certain key expectations and assumptions made by the management of Victory Square. Although Victory Square believes that the expectations and assumptions on which such forward looking information is based are reasonable, undue reliance should not be placed on them because Victory Square can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements contained in this news release are made as of the date of this news release. Victory Square disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.

  • GlobeNewswire

    Victory Square Technologies Portfolio Company Applies to Health Canada for Approval of its Safetest Covid-19™ Rapid Test for Sale & Distribution in Canada

    * Victory Square Health formally submits all required Safetest Rapid Test documents to Health Canada * Victory Square Health received an order of 2,000,000 units of Safetest Covid-19™ Test Kits from TM Safety Supplies subject to Health Canada approval * Company has entered Into a Distribution & Testing Agreement With the Canadian Police Association to Provide Safetest Covid-19™ Test Kits & On-Site Testing Services to Over 60,000 Members in Canada * The Company has secured internal and external manufacturing facilities to increase the monthly production of its Covid-19 Safetest Rapid Tests to meet demandVANCOUVER, British Columbia, Oct. 06, 2020 (GLOBE NEWSWIRE) -- Victory Square Health Inc. (“VS Health” or the "Company") – a portfolio company of Victory Square Technologies Inc. ("Victory Square'') (CSE:VST) (OTC:VSQTF) (FWB:6F6) is pleased to update stakeholders on the Company’s progress in Canada.Victory Square Health has taken the critical extra steps to improve the accuracy and specificity results for its Safetest Covid-19 Rapid Test, so its clinical performance meets Health Canada’s standards. Based on these improved results, the Company has now formally submitted its Safetest Covid-19 Rapid tests to Health Canada for formal review and approval.Victory Square Health previously announced in September, 2020 that it had engaged with a Government-recognized manufacturer, and also acquired its own additional lab and manufacturing facility to increase monthly production of its Covid-19 Safetest Rapid Tests. The Company is confident that it will deliver upon orders in a timely manner and without delay in Canada following Health Canada approvals.Victory Square Health has combined its Safetest Covid-19 Test with a turn-key testing-as-a-service suite of products and services including providing companies with certified on-site testing teams, medical professionals, lab analysis, and a digital health passport with encrypted and secure data of testing date, time, results. Victory Square Health can provide Covid-19 testing-as-a-service to large and small scale companies, government organizations, the public as well as for border agencies, airports, and public entertainment spaces. This turn-key testing-as-a-service is in addition to its proprietary Safetest Covid-19™ Test. This service will alleviate the pressure that companies and Government agencies would face having to deal with the logistics of initiating testing on their own.“Victory Square Health is ready to assist large and small companies, organizations, government, and public agencies through our Covid-19 Safetest turn-key testing-as-a-service,” said Shafin Diamond Tejani, CEO of Victory Square. “As a proud Canadian Company, our commitment to our fellow Canadians is paramount during this wave and future waves of this pandemic.”Victory Square recently announced that it had entered into a distribution and partnership agreement in Canada with The Canadian Police Association and TM Safety Supplies following Health Canada approvals. These sales and distribution announcements are the first in Canada of which the Company expects to be many in the coming weeks and months. The Canadian Police Association and its 60,000 plus members work day and night in contact with countless people. Their safety and knowledge from our Safetest Covid-19 Test is a priority. TM Safety Supplies provides a complete catalogue of personal protective equipment, sanitization items, gowns, critical supplies, and is now adding the <15 minute Safetest Covid-19 Rapid Test to its product arsenal.VS Health was founded in 2016 to accelerate the development of personalized medicine and technology solutions including diagnostic tests to support patient’s care and improve health outcomes. Its first product, the Leishmaniasis Rapid Test, was developed in partnership with the UFMG, Federal University of Minas Gerais. Safetest took advantage of its expertise in the subject to develop other antibody-based tests and a robust R&D pipelines of diagnostic kits for Hansen’s Disease, Brucellosis, HTLV and Blood samples screening tests as well as on-site diagnostics and testing services.Below is a quick recap from the Company’s most recent News releases, which can all be found at www.victorysquare.com/blog:September 30th - Victory Square Technologies Portfolio Company Enters Into a Distribution & Testing Agreement With the Canadian Police Association to Provide Safetest Covid-19 Testing Kits & On-Site Testing Services to Over 60,000 Members in CanadaSeptember 28th - Victory Square Technologies Portfolio Company receives an order of Safetest Covid-19 Testing Kits from North America’s TM Safety Supplies CompanySeptember 25th - Victory Square Technologies Portfolio Company Acquires Brazilian Manufacturing & Laboratory Facility to Increase Production of its Covid-19 Testing Products by an additional 4,000,000 Units in BrazilSeptember 22nd \- Victory Square Health Announces Order of 2 Million (2,000,000) UNITS for its Safetest Covid-19™ Test in Brazil.September 18th \- Victory Square Technologies Portfolio Company V2 Games Acquires Techstars 2019 Alumni Company “GameOn”September 17th - Victory Square Provides Corporate Update on the Strong Performance of Portfolio CompaniesSeptember 14th - Victory Square Technologies Portfolio Company Receives Approval for Sale and Use of Safetest Covid-19 Antibody Test for the European UnionSeptember 8th - Victory Square Technologies Portfolio Company Receives Brazilian ANVISA Approval for Sale & Use of Safetest Covid-19 Antibody Test for the Country of BrazilSeptember 2nd - Victory Square Health Increases Monthly Production of Rapid Covid-19 Test Kits to Meet Increased Demand with New Manufacturing Agreement with Gold Analisa Diagnostica LtdaSeptember 1st - Victory Square Technologies Reports a Record First Half 2020August 31st - Victory Square Technologies to Present at the LD 500 Virtual ConferenceAugust 27th - Victory Square Technologies Portfolio Company is the first to be approved by the São Paulo State Government Covid-19 Innovation ProgrammeAugust 25th - Victory Square Technologies Portfolio Company Gets FDA Permission to Manufacture and Market Safetest Covid-19 Antibody TestDisclaimer:The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the Covid-19 (or SARS-2 Coronavirus) at this time.Check out VictorySquare.com and sign up to VST's official newsletter at www.VictorySquare.com/newsletter.On behalf of the board,Shafin Diamond Tejani Chief Executive Officer Victory Square TechnologiesFor further information about the Company, please contact:Investor Relations Contact – Alex TziliosEmail: alexandros@victorysquare.comTelephone: 778-867-0482Media Relations Contact – Howard Blank, DirectorEmail: howard@victorysquare.comTelephone: 604-928-6066ABOUT VICTORY SQUARE TECHNOLOGIES INC.Victory Square (VST) builds, acquires and invests in promising startups, then provides the senior leadership and resources needed to fast-track growth.VST's sweet spot is the cutting-edge tech that's shaping the 4th Industrial Revolution. Our portfolio consists of 20 global companies using AI, VR/AR and blockchain to disrupt sectors as diverse as fintech, insurance, health and gaming.What we do differently for startupsVST isn't just another investor. With real skin in the game, we're committed to ensuring each company in our portfolio succeeds. Our secret sauce starts with selecting startups that have real solutions, not just ideas. We pair you with senior talent in product, engineering, customer acquisition and more. Then we let you do what you do best — build, innovate and disrupt. In 24-36 months, you'll scale and be ready to monetize.What we do differently for investorsVST is a publicly traded company headquartered in Vancouver, Canada, and listed on the Canadian Securities Exchange (VST), Frankfurt Exchange (6F6) and the OTCQX (VSQTF).For investors, we offer early-stage access to the next unicorns before they're unicorns.Our portfolio represents a unique way for investors to get access to the latest cutting-edge technologies, while also tapping into emerging global trends with big upsides. For more information, please visit www.victorysquare.com.Forward Looking StatementThis news release contains “forward-looking information” within the meaning of applicable securities laws relating to the outlook of the business of Victory Square, including, without limitation, statements relating to future performance, execution of business strategy, future growth, business prospects and opportunities of Victory Square and its related subsidiaries, including Victory Square Health Inc., and other factors beyond our control. Such forward-looking statements may, without limitation, be preceded by, followed by, or include words such as “believes”, “expects”, “anticipates”, “estimates”, “intends”, “plans”, “continues”, “project”, “potential”, “possible”, “contemplate”, “seek”, “goal”, or similar expressions, or may employ such future or conditional verbs as “may”, “might”, “will”, “could”, “should” or “would”, or may otherwise be indicated as forward-looking statements by grammatical construction, phrasing or context. All statements other than statements of historical facts contained in this news release are forward-looking statements. Forward-looking information is based on certain key expectations and assumptions made by the management of Victory Square. Although Victory Square believes that the expectations and assumptions on which such forward looking information is based are reasonable, undue reliance should not be placed on them because Victory Square can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements contained in this news release are made as of the date of this news release. Victory Square disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.

  • GlobeNewswire

    Victory Square Technologies Comments on Recent Promotional Activity Pursuant to OTC Markets Request

    Not for distribution to Canadian Newswire Services or for Dissemination in CanadaVANCOUVER, British Columbia, Oct. 01, 2020 (GLOBE NEWSWIRE) -- Victory Square Technologies Inc. ("Victory Square'') (CSE:VST) (OTC:VSQTF) (FWB:6F6), today announced that it has implemented an expanded shareholder communications initiative to provide greater transparency into the Company's business plans and growth strategy.“The Company plans to communicate more effectively with shareholders on an ongoing basis in order to supply relevant company information,” said Shafin Diamond Tejani, CEO of Victory Square. “With portfolio companies that are fast-paced and growing rapidly, we thought it prudent to communicate more regularly with our investor base,” added Mr. Tejani.As part of its multi-channel approach, Victory Square presented at the LD 500 Virtual Conference hosted by LD Micro on September 2nd, will be presenting at the Proactive One2One Investor Forum on October 27th, and has engaged Electrik Dojo, LLC to increase brand visibility and to deliver pertinent company information via email communications, websites and other digital resources through authorized content publishers in the United States.1\. On September 22, 2020, the Company became aware of promotional activities that included email communications attached to a published article about the Company sent by Electrik Dojo, LLC. The promotional activities did not have an effect on the trading activity of the Company’s security.2\. Neither the Company nor its officers were involved in the content creation or the distribution of the promotional content. The information was taken from the company's press releases and investor presentation deck. The Company provided payment for services only. The company had no editorial control over third party’s content.3\. Statements made in the promotional materials are not materially false and/or misleading.4\. After inquiry of management, no directors, the Company, or its officers have not sold nor purchased the Company’s securities within the past 90 days. As per announcement on September 9th, 2020, A large shareholder sold Common Shares of Victory Square Technologies.5\. Electrik Dojo, LLC is the third party provider engaged by the Company to provide marketing or other related services including the promotion of the Company from September 15, 2020 to October 15, 2020. In 2019, the Company also worked with a third party provider, NativeAds Inc. in October 2019 for marketing services.6\. The Company has not at any point issued shares or convertible instruments allowing conversion to equity securities at prices constituting a discount to the current market rate at the time of the issuance.Below is a quick recap from the Company’s most recent News releases, which can all be found at www.victorysquare.com/blog:September 28th - Victory Square Technologies Portfolio Company receives an order of Safetest Covid-19 Testing Kits from North America’s TM Safety Supplies CompanySeptember 25th - Victory Square Technologies Portfolio Company Acquires Brazilian Manufacturing & Laboratory Facility to Increase Production of its Covid-19 Testing Products by an additional 4,000,000 Units in BrazilSeptember 22nd \- Victory Square Health Announces Order of 2 Million (2,000,000) UNITS for its Safetest Covid-19™ Test in Brazil.September 18th \- Victory Square Technologies Portfolio Company V2 Games Acquires Techstars 2019 Alumni Company “GameOn”September 17th - Victory Square Provides Corporate Update on the Strong Performance of Portfolio CompaniesSeptember 14th - Victory Square Technologies Portfolio Company Receives Approval for Sale and Use of Safetest Covid-19 Antibody Test for the European UnionSeptember 8th - Victory Square Technologies Portfolio Company Receives Brazilian ANVISA Approval for Sale & Use of Safetest Covid-19 Antibody Test for the Country of BrazilSeptember 2nd - Victory Square Health Increases Monthly Production of Rapid Covid-19 Test Kits to Meet Increased Demand with New Manufacturing Agreement with Gold Analisa Diagnostica LtdaSeptember 1st - Victory Square Technologies Reports a Record First Half 2020August 31st - Victory Square Technologies to Present at the LD 500 Virtual ConferenceAugust 27th - Victory Square Technologies Portfolio Company is the first to be approved by the São Paulo State Government Covid-19 Innovation ProgrammeAugust 25th - Victory Square Technologies Portfolio Company Gets FDA Permission to Manufacture and Market Safetest Covid-19 Antibody TestCheck out VictorySquare.com and sign up to VST's official newsletter at www.VictorySquare.com/newsletter.On behalf of the board,Shafin Diamond TejaniChief Executive OfficerVictory Square TechnologiesFor further information about the Company, please contact:Investor Relations Contact – Alex TziliosEmail: alexandros@victorysquare.comTelephone: 778-867-0482Media Relations Contact – Howard Blank, DirectorEmail: howard@victorysquare.comTelephone: 604-928-6066ABOUT VICTORY SQUARE TECHNOLOGIES INC.Victory Square (VST) builds, acquires and invests in promising startups, then provides the senior leadership and resources needed to fast-track growth.VST's sweet spot is the cutting-edge tech that's shaping the 4th Industrial Revolution. Our portfolio consists of 20 global companies using AI, VR/AR and blockchain to disrupt sectors as diverse as fintech, insurance, health and gaming.What we do differently for startupsVST isn't just another investor. With real skin in the game, we're committed to ensuring each company in our portfolio succeeds. Our secret sauce starts with selecting startups that have real solutions, not just ideas. We pair you with senior talent in product, engineering, customer acquisition and more. Then we let you do what you do best — build, innovate and disrupt. In 24-36 months, you'll scale and be ready to monetize.What we do differently for investorsVST is a publicly traded company headquartered in Vancouver, Canada, and listed on the Canadian Securities Exchange (VST), Frankfurt Exchange (6F6) and the OTCQX (VSQTF).For investors, we offer early-stage access to the next unicorns before they're unicorns.Our portfolio represents a uniquely liquid and secure way for investors to get access to the latest cutting-edge technologies while also tapping into emerging global trends with big upsides. For more information, please visit www.victorysquare.com.Forward Looking StatementThis news release contains “forward-looking information” within the meaning of applicable securities laws relating to the outlook of the business of Victory Square, including, without limitation, statements relating to future performance, execution of business strategy, future growth, business prospects and opportunities of Victory Square and its related subsidiaries, including Victory Square Health Inc., and other factors beyond our control. Such forward-looking statements may, without limitation, be preceded by, followed by, or include words such as “believes”, “expects”, “anticipates”, “estimates”, “intends”, “plans”, “continues”, “project”, “potential”, “possible”, “contemplate”, “seek”, “goal”, or similar expressions, or may employ such future or conditional verbs as “may”, “might”, “will”, “could”, “should” or “would”, or may otherwise be indicated as forward-looking statements by grammatical construction, phrasing or context. All statements other than statements of historical facts contained in this news release are forward-looking statements. Forward-looking information is based on certain key expectations and assumptions made by the management of Victory Square. Although Victory Square believes that the expectations and assumptions on which such forward looking information is based are reasonable, undue reliance should not be placed on them because Victory Square can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements contained in this news release are made as of the date of this news release. Victory Square disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.

  • GlobeNewswire

    Victory Square Technologies Portfolio Company Enters Into a Distribution & Testing Agreement With the Canadian Police Association to Provide Safetest Covid-19 Testing Kits & On-Site Testing Services to Over 60,000 Members in Canada

    * The Canadian Police Association represents over 60,000 police personnel serving in 160 police services across Canada * Victory Square Health will offer Safetest Covid-19 Testing Kits, on-site testing professionals and diagnostics to the Canadian Police Association following Health Canada approvals * Assisting Front Line Heroes is a priority for Victory Square Health VANCOUVER, British Columbia, Sept. 29, 2020 (GLOBE NEWSWIRE) -- Victory Square Health Inc. (“VS Health” or the "Company") – a portfolio company of Victory Square Technologies Inc. ("Victory Square'') (CSE:VST) (OTC:VSQTF) (FWB:6F6) -- is pleased to announce that it has entered into a partnership agreement to provide Safetest Covid-19 Testing Kits to the Canadian Police Association representing 60,000 active police members who serve from coast to coast in Canada. This is subject to Health Canada approval.The Canadian Police Association (CPA) is the national voice for 60,000 police personnel across Canada. Membership includes police personnel serving in 160 police services from Canada's smallest towns and villages as well as those working in Canada’s largest municipal and provincial police services, and railway police. The Association also has an affiliation with court personnel, jail guards and First Nations’ police and service personnel across the country. Through the Canadian Police Association; the offer for Victory Square testing kits & services will be made to the RCMP (Royal Canadian Mounted Police) and its additional more than 20,000 law enforcement members across Canada.This distribution agreement will enable Victory Square Health to support the Canadian Police Association as they continue to keep all Canadian’s safe during these unprecedented times. The Canadian Police Association’s 60,000 members who serve on the front lines will be equipped to receive Covid-19 test results in a much quicker fashion with the Safetest suite of products. Victory Square Health will also offer software and end-to-end encryption protocols to the Association as well as on-site testing professionals and diagnostics as requested following Health Canada approvals.“We are very pleased to work with Victory Square,” said Canadian Police Association President Tom Stamatakis. “We believe that the Victory Square Covid-19 Safetest products and on-site testing services will be a critical piece to ensuring the safety of our officers who wear the badge and serve and protect us across Canada,” said Stamatakis. “The Safetest Covid-19 products and testing will be made available for wide distribution as well as one-stop testing and on-site analysis by Victory Square to our members following Health Canada approvals.”“We are very delighted to enter into a distribution and testing agreement with The Canadian Police Association and its more than 60,000 heroes who wear the badge to keep our cities and communities safe, along with its members in the justice, and jail system across the country,” said Victory Square CEO Shafin Diamond Tejani. “We are pleased to offer the first responders, and organizations with our exclusive Safetest products and services in their plight to ensure that their front-line personnel are kept safe and informed during this pandemic.”Victory Square Health is also proud to step up and assist our Heroes who wear the badge by providing complimentary Safetest Covid-19 testing to all family members of police officers who test positive for the virus.VS Health was founded in 2016 to accelerate the development of personalized medicine and technology solutions including diagnostic tests to support patient’s care and improve health outcomes. Its first product, the Leishmaniasis Rapid Test, was developed in partnership with the UFMG, Federal University of Minas Gerais. Safetest took advantage of its expertise in the subject to develop other antibody-based tests and a robust R&D pipelines of diagnostic kits for Hansen’s Disease, Brucellosis, HTLV and Blood samples screening tests.Disclaimer:The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the Covid-19 (or SARS-2 Coronavirus) at this time.Check out VictorySquare.com and sign up to VST's official newsletter at www.VictorySquare.com/newsletter.On behalf of the board,Shafin Diamond TejaniChief Executive OfficerVictory Square TechnologiesFor further information about the Company, please contact:Investor Relations Contact – Alex TziliosEmail: alexandros@victorysquare.comTelephone: 778-867-0482Media Relations Contact – Howard Blank, DirectorEmail: howard@victorysquare.comTelephone: 604-928-6066ABOUT VICTORY SQUARE TECHNOLOGIES INC.Victory Square (VST) builds, acquires and invests in promising startups, then provides the senior leadership and resources needed to fast-track growth.VST's sweet spot is the cutting-edge tech that's shaping the 4th Industrial Revolution. Our portfolio consists of 20 global companies using AI, VR/AR and blockchain to disrupt sectors as diverse as fintech, insurance, health and gaming.What we do differently for startupsVST isn't just another investor. With real skin in the game, we're committed to ensuring each company in our portfolio succeeds. Our secret sauce starts with selecting startups that have real solutions, not just ideas. We pair you with senior talent in product, engineering, customer acquisition and more. Then we let you do what you do best — build, innovate and disrupt. In 24-36 months, you'll scale and be ready to monetize.What we do differently for investorsVST is a publicly traded company headquartered in Vancouver, Canada, and listed on the Canadian Securities Exchange (VST), Frankfurt Exchange (6F6) and the OTCQX (VSQTF).For investors, we offer early-stage access to the next unicorns before they're unicorns.Our portfolio represents a uniquely liquid and secure way for investors to get access to the latest cutting-edge technologies while also tapping into emerging global trends with big upsides. For more information, please visit www.victorysquare.com.Forward Looking StatementThis news release contains “forward-looking information” within the meaning of applicable securities laws relating to the outlook of the business of Victory Square, including, without limitation, statements relating to future performance, execution of business strategy, future growth, business prospects and opportunities of Victory Square and its related subsidiaries, including Victory Square Health Inc., and other factors beyond our control. Such forward-looking statements may, without limitation, be preceded by, followed by, or include words such as “believes”, “expects”, “anticipates”, “estimates”, “intends”, “plans”, “continues”, “project”, “potential”, “possible”, “contemplate”, “seek”, “goal”, or similar expressions, or may employ such future or conditional verbs as “may”, “might”, “will”, “could”, “should” or “would”, or may otherwise be indicated as forward-looking statements by grammatical construction, phrasing or context. All statements other than statements of historical facts contained in this news release are forward-looking statements. Forward-looking information is based on certain key expectations and assumptions made by the management of Victory Square. Although Victory Square believes that the expectations and assumptions on which such forward looking information is based are reasonable, undue reliance should not be placed on them because Victory Square can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements contained in this news release are made as of the date of this news release. Victory Square disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.

  • Vumetric Cybersecurity Has Been Awarded the Cyber Essential Certification
    CNW Group

    Vumetric Cybersecurity Has Been Awarded the Cyber Essential Certification

    MONTREAL, Sept. 28, 2020 /CNW Telbec/ - Vumetric Cybersecurity Inc.